Show simple item record

dc.contributor.authorAli, FM
dc.contributor.authorJohns, Nutjaree
dc.contributor.authorSalek, Mir-Saeed Shayegan
dc.contributor.authorFinlay, Andrew Y.
dc.date.accessioned2019-01-03T01:16:27Z
dc.date.available2019-01-03T01:16:27Z
dc.date.issued2018-11-01
dc.identifier.citationAli , FM , Johns , N , Salek , M-S S & Finlay , A Y 2018 , ' Correlating the Dermatology Life Quality Index with psychiatric measures: A systematic review. ' , Clinical Dermatology , vol. 36 , no. 6 , pp. 691-697 . https://doi.org/10.1016/j.clindermatol.2018.08.014
dc.identifier.issn0738-081X
dc.identifier.otherPURE: 15703178
dc.identifier.otherPURE UUID: c5967dcf-1c60-4bf9-b754-a1b1b76c192d
dc.identifier.otherScopus: 85056465200
dc.identifier.urihttp://hdl.handle.net/2299/20907
dc.description© 2018 Published by Elsevier Inc. All rights reserved.
dc.description.abstractSkin conditions may have a major impact on the psychologic well-being of patients, ranging from depression to anxiety. The Dermatology Life Quality Index (DLQI) is the most commonly used quality of life tool in dermatology, though it has yet to be correlated with psychiatric measures used in clinical therapeutic trials. We conducted a systematic review to determine whether there is any correlation between the DLQI and psychiatric measure scores, potentially allowing the DLQI to be used as a surrogate measure for depression or psychiatric screening. Six databases were searched using the following keywords: "DLQI," "Dermatology Life Quality Index," "Psych*," "depression," "anxiety," "stress," and "trial*." All randomized trials where full DLQI and psychiatric scores were provided were included. PRISMA guidelines were followed. In all, 462 records were screened, but only seven met inclusion criteria. Hospital Anxiety and Depression Scale (HADS) was the most commonly used psychiatric measure; the "depression" component score changes correlated strongly with the DLQI (r = 0.715). There needs to be guidance on psychiatric measurement and reporting in clinical trials. Although the DLQI correlated well with the "depression" domain of the HADS scale, interviews and screening for depression are still vital for full assessment of patient psychologic well-being.en
dc.format.extent7
dc.language.isoeng
dc.relation.ispartofClinical Dermatology
dc.subjectDermatology
dc.titleCorrelating the Dermatology Life Quality Index with psychiatric measures: A systematic review.en
dc.contributor.institutionDepartment of Pharmacy, Pharmacology and Postgraduate Medicine
dc.contributor.institutionPublic Health and Patient Safety Unit
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Clinical and Pharmaceutical Sciences
dc.description.statusPeer reviewed
dc.date.embargoedUntil2019-11-13
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85056465200&partnerID=8YFLogxK
rioxxterms.versionAM
rioxxterms.versionofrecordhttps://doi.org/10.1016/j.clindermatol.2018.08.014
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record